Patrick Serruys News Today

Abbott's landmark LIFE-BTK randomized clinical trial met its primary safety and effectiveness endpoints, demonstrating that Esprit BTK offers significant advancements in opening and keeping blocked arteries below-the-knee open compared to the standard of care, balloon angioplasty 

New clinical data support use of lesion-specific FFRCT for diagnosis and treatment of patients with coronary artery disease

FAME 3 was negative, rendering this prespecified analysis hypothesis-generating, but the findings make sense to FFR users.

Neither PCI nor CABG is going away, and both play important roles in coronary revascularization, says surgeon Mario Gaudino.

A low pullback pressure gradient indicates diffuse coronary disease that probably won’t respond well to stenting.

The US and Harvard University continue to dominate the global Highly Cited Researchers list, but China is closing in on the gap with each passing year.

Mission Viejo, California, United States, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Leonhardt Ventures, LLC  is pleased to announce the United States Patent and...

Birmingham [England], September 14 (ANI/PRNewswire): Concept Medical announces the successful completion of the TRANSFORM 1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial FOR MagicTouch Sirolimus Coated Balloon). The Randomized Controlled Trial (RCT) was conceptualized with the aim of understanding how the treatment indications and applications of Drug-Coated Balloon (DCB) in coronary artery disease (CAD) can be broadened. This prospective, randomized, multi-centre, RCT fo...

BIRMINGHAM, England, Sept. 13, 2022 /PRNewswire/ -- Concept Medical announces the successful completion of the TRANSFORM 1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial

/PRNewswire/ -- Concept Medical announces the successful completion of the TRANSFORM 1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial...